Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T09:06:33.993Z Has data issue: false hasContentIssue false

The Pathology of a Cross-over Trial (Thiazesim—A New Anti-depressant Drug)

Published online by Cambridge University Press:  29 January 2018

Rowland Berry
Affiliation:
Department of Psychological Medicine St. Bartholomew's Hospital, London, E.C.I
Paul Turner
Affiliation:
Wellcome Senior Research Fellow in Clinical Science, Medical Professorial Unit St. Bartholomew's Hospital, London, E.C.I

Extract

The work described in this paper began as just another drug trial. The authors' interest was aroused by the possibility of a new, fast-acting anti-depressant, unrelated to the monoamine oxidase inhibitors or tricyclic compounds.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Armitage, P. (1960). Sequential Medical Trials. London.Google Scholar
Barratt, E. S., and Pray, S. L. (1965). Exp. Neurol., 12, 173.Google Scholar
Cromie, B. W. (1963). Lancet, ii, 994.Google Scholar
Dreyfuss, J., Swoap, J. R., and Hess, S. M. (1966). Fed. Proc., 25, 532.Google Scholar
Freeman, H., Oktem, M. R., Kristofferson, M. W., and Gorby, C. K. (1965). Curr. Ther. Res., 7, 655.Google Scholar
Horovitz, Z. P., Furgiuele, A. R., Brannick, L. J., Burke, J. C., and Graver, B. N. (1963). Nature, Lond., 200, 369.Google Scholar
Turner, P. (1964). J. med. Wom. Fed., 46, 212.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.